The global hypercoagulability market is poised for significant growth between 2024 and 2032, driven by the increasing prevalence of coagulation disorders and the rising awareness of related health issues. Hypercoagulability, a condition characterized by an increased tendency for blood to clot, poses serious health risks, including deep vein thrombosis (DVT), pulmonary embolism, and stroke....
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Russian
Romaian